Stay updated on Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check19 days agoChange DetectedA banner announces NIH website updates and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.7%

- Check26 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check33 days agoChange DetectedThe website footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry v3.7.0 was added to the Study Record Versions. The previous entry v3.6.6 was removed from the list in the history.SummaryDifference0.1%

- Check75 days agoChange DetectedThe record history now shows a new revision v3.6.6 and removes the previous revision v3.6.5, indicating the study record has been updated to a newer version. This reflects version control activity rather than changes to the substantive study data.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.